Measuring the impact of global research and development investment in product development partnerships: a case study on return on investment in antimalarial drug development

Journal:

The Lancet Global Health

Published:

2026-03-01

DOI:

10.1016/s2214-109x(25)00456-5

Affiliations:

5

Authors:

6

Go to article

Institutions	Authors	Share
Cambridge Economic Policy Associates (CEPA), United Kingdom (UK)	2.000000	0.33
MRC Centre for Global Infectious Disease Analysis (MRC GIDA), United Kingdom (UK)	1.000000	0.17
Medicines for Malaria Venture (MMV), Switzerland	1.000000	0.17
Foreign and Commonwealth Office (FCO), United Kingdom (UK)	1.000000	0.17
London School of Economics and Political Science (LSE), United Kingdom (UK)	1.000000	0.17

Interested in Applied Economics?